H19 and congenital bilateral aplasia of vas deferens from CFTR mutation: Mathieu and colleagues reported that a dysregulation of DNA methylation in the promoter of H19 during CAVD upregulates its expression, which promotes an osteogenic program by interfering with the expression of NOTCH1 [6].